Aethlon Medical, Inc. (AEMD) Research

Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.

Market snapshot

Symbol
AEMD
Price
$1.89
Day change
-1.05%
Market cap
$1.4M
P/E ratio
-0.42x
52-week range
1.36-27.4
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • Adaptimmune Therapeutics plc (ADAP)
  • Allurion Technologies Inc. (ALUR)
  • Co-Diagnostics, Inc. (CODX)
  • Ernexa Therapeutics Inc. (ERNA)
  • Inspira Technologies Oxy B.H.N. Ltd. (IINN)
  • Lunai Bioworks Inc. (LNAI)
  • enVVeno Medical Corporation (NVNO)
  • Tenon Medical, Inc. (TNON)

Recent insider activity

  • Rossetti Angela — A-Award (21815 shares) on 2026-04-17
  • Shah Chetan — A-Award (21815 shares) on 2026-04-17
  • BROENNIMAN EDWARD G — A-Award (21815 shares) on 2026-04-17
  • Gikakis Nicolas — A-Award (21815 shares) on 2026-04-17
  • Shah Chetan — F-InKind (178 shares) on 2026-03-31

Open Aethlon Medical, Inc. (AEMD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.